Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors

Human Gene Therapy

Volumn 13, Issue 5, 2002, Pages 613-626

  Nakamura, Takafumi ^a   Kenzo, Sato ^a   Hamada, Hirofumi ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ARGININE; ASPARTIC ACID; BETA3 INTEGRIN; GLYCINE; INTEGRIN RECEPTOR; INTERLEUKIN 12; ISOPROTEIN; PEPTIDE; VIRUS PROTEIN; VIRUS RECEPTOR;

ADENOVIRUS 5; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DNA MODIFICATION; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL MELANOMA; FEMALE; GENE MUTATION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; TUMOR XENOGRAFT; VIROGENESIS; WILD TYPE;

ADENOVIRIDAE; ANIMALS; FEMALE; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTEGRINS; MELANOMA; MICE; MICE, INBRED BALB C; RECEPTORS, VIRUS; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; ANIMALIA; COXSACKIEVIRUS; HUMAN ADENOVIRUS TYPE 5; INSERTION SEQUENCES; MUS MUSCULUS;

EID: 0036202814     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340252837215     Document Type: Article

References (42)

1. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors
2. Integrin distribution in malignant melanoma: Association of the β3 subunit with tumor progression
3. A multifactorial analysis of melanoma. III. Prognostic factors in melanoma patients with lymph node metastases (stage II)
4. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
5. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients
6. Adenovirus-mediated in vivo gene transfer
7. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo
8. Model predicting survival in stage I melanoma based on tumor progression
9. Current treatment options for malignant melanoma
10. Histochemical staining following lacZ gene transfer underestimates transfection efficiency
11. Pathology of malignant melanoma, including new markers and techniques in diagnosis and prognosis
12. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a cox-sackievirus and adenovirus receptor-independent cell entry mechanism
13. Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses
14. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures
15. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts
16. Integrins: Versatility, modulation, and signaling in cell adhesion
17. Viral vector systems for gene therapy
18. 3 expression on blood vessels and melanoma cells in primary lesions: Differential association with tumor progression and clinical prognosis
19. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase
20. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector
21. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob
22. Intracellular uncoating of type 5 adenovirus deoxyribonucleic acid
23. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome
24. A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma
25. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2
26. Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2
27. Phase I trial of interferon υ retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma
28. Sensitivity and reproducibility in adenoviral infectious titer determination
29. v integrins as receptors for tumor targeting by circulating ligands
30. Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression
31. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing Adenoviridae
32. RGD and other recognition sequences for integrins
33. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer
34. The ratio of physical particles per infectious unit observed for poliomyelitis viruses
35. Progression clinical and pathological features
36. Molecular role(s) for integrins in human melanoma invasion
37. Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: Results of a phase 1 clinical trial
38. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
39. Malignant melanoma of the skin. Pathogenesis, clinical aspects and prognosis
40. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
41. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal
42. Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma